Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| CCEL | CRYO CELL INTERNATIONAL INC | 2025-12-02 08:00:00 | 3.97 | -0.01 | -0.25 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CCEL | 0000862692 | CRYO CELL INTERNATIONAL INC | US2288951088 | 254900AQWFD6AR2J7Z30 | 223023093 | NYSE | 8090 | Services-Misc Health & Allied Services, NEC | 1130 | DE | 700 BROOKER CREEK BLVD | OLDSMAR | FL | 34677 | UNITED STATES | US | 813-749-2104 | 700 BROOKER CREEK BLVD, OLDSMAR, FL, 34677 | 700 BROOKER CREEK BLVD, OLDSMAR, FL, 34677 | — | — | 1989 | — | — | http://cryo-cell.com | 43,849,869 | 14,877,119 | 8,055,150 | Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL. | 2025-11-27 20:01:17 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2024 | 43,849,869 | 16,839,443 | 62.3442 | 8,082,159 | -204,626 | -2.4693 |
| 2023 | 27,010,426 | -8,438,665 | -23.805 | 8,286,785 | -156,531 | -1.8539 |
| 2022 | 35,449,091 | -12,158,104 | -25.5384 | 8,443,316 | -59,302 | -0.6975 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Oleg Mikulinsky | Chief Information Officer | 2024 | 329,889 | 63,000 | 0 | — | — | 430,950 |
| Mark Portnoy | Co-Chief Executive Officer | 2024 | 556,687 | 450,000 | 0 | — | — | 1,211,713 |
| David Portnoy | Co-Chief Executive Officer | 2024 | 721,632 | 750,000 | 0 | — | — | 1,884,353 |
| Jill Taymans | Chief Financial Officer, Vice President | 2024 | 280,000 | 20,000 | 0 | — | — | 322,931 |
| David Portnoy | Co-Chief Executive Officer | 2023 | 700,000 | 750,000 | 0 | — | — | 1,869,397 |
| Fiscal Year | Employee Count |
|---|---|
| 2024 | 82 |
| 2023 | 82 |
| 2022 | 80 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 31,986,106 | 31,343,695 | 30,336,749 |
| Cost Of Revenue | 7,947,752 | 8,442,310 | 8,792,358 |
| Gross Profit | — | — | — |
| Research And Development Expenses | 1,242,536 | 1,171,456 | 384,789 |
| General And Administrative Expenses | 18,521,218 | 17,115,514 | 15,580,274 |
| Operating Expenses | 28,505,822 | 43,647,727 | 26,312,282 |
| Operating Income | 3,480,284 | -12,304,032 | 4,024,467 |
| Net Income | 402,095 | -9,521,669 | 2,771,408 |
| Earnings Per Share Basic | 0.05 | -1.14 | 0.33 |
| Earnings Per Share Diluted | 0.05 | -1.14 | 0.33 |
| Weighted Average Shares Outstanding Basic | 8,130,676 | 8,340,839 | 8,465,568 |
| Weighted Average Shares Outstanding Diluted | 8,212,510 | 8,340,839 | 8,483,994 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Cash And Cash Equivalents | 560,960 | 406,067 | 1,703,958 |
| Marketable Securities Current | 2,935,183 | 574,183 | 17,620 |
| Accounts Receivable | 7,309,094 | 6,576,240 | 6,043,941 |
| Inventories | 657,703 | 768,877 | 851,230 |
| Non Trade Receivables | — | — | — |
| Other Assets Current | 454,598 | 389,950 | 426,879 |
| Total Assets Current | 12,554,593 | 9,452,837 | 9,610,185 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | 21,894,263 | 20,996,883 | 13,603,115 |
| Other Assets Non Current | 30,228,777 | 30,771,050 | 41,674,754 |
| Total Assets Non Current | 52,123,040 | 51,767,933 | 55,277,869 |
| Total Assets | 64,677,633 | 61,220,770 | 64,888,054 |
| Accounts Payable | 1,882,274 | 3,174,584 | 1,605,301 |
| Deferred Revenue | 9,788,574 | 9,704,553 | 9,586,327 |
| Short Term Debt | 3,520,000 | 1,222,728 | 2,272,728 |
| Other Liabilities Current | 5,809,872 | 5,170,809 | 3,585,810 |
| Total Liabilities Current | 21,599,542 | 20,864,001 | 19,481,420 |
| Long Term Debt | 8,480,533 | 8,595,678 | 8,730,402 |
| Other Liabilities Non Current | 56,294,108 | 51,388,001 | 46,930,936 |
| Total Liabilities Non Current | 56,294,108 | 51,388,001 | 46,930,936 |
| Total Liabilities | 77,893,650 | 72,252,002 | 66,412,356 |
| Common Stock | 148,696 | 148,492 | 148,480 |
| Retained Earnings | -32,777,626 | -31,159,182 | -21,637,513 |
| Accumulated Other Comprehensive Income | — | — | — |
| Total Shareholders Equity | -13,216,017 | -11,031,232 | -1,524,302 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Depreciation And Amortization | 483,522 | 1,124,228 | 1,119,528 |
| Share Based Compensation Expense | 781,128 | 816,639 | 461,345 |
| Other Non Cash Income Expense | — | 0 | 407,344 |
| Change In Accounts Receivable | 1,999,759 | 1,568,689 | 1,720,386 |
| Change In Inventories | -429,178 | -360,445 | -490,002 |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | — | — | — |
| Change In Accounts Payable | -423,720 | 688,935 | 115,527 |
| Change In Other Liabilities | 639,063 | 1,582,135 | 528,424 |
| Cash From Operating Activities | 6,010,910 | 8,919,754 | 8,572,647 |
| Purchases Of Marketable Securities | — | — | — |
| Sales Of Marketable Securities | 1,516,359 | 397,831 | 1,161,032 |
| Acquisition Of Property Plant And Equipment | 2,403,708 | 6,838,969 | 12,168,459 |
| Acquisition Of Business | — | — | — |
| Other Investing Activities | — | — | — |
| Cash From Investing Activities | -4,876,899 | -8,144,754 | -15,279,639 |
| Tax Withholding For Share Based Compensation | — | — | — |
| Payments Of Dividends | 2,020,539 | — | 7,672,728 |
| Issuance Of Common Stock | — | — | — |
| Repurchase Of Common Stock | 1,423,871 | 799,036 | 1,819,915 |
| Issuance Of Long Term Debt | — | — | — |
| Repayment Of Long Term Debt | 2,922,728 | 2,000,000 | 5,400,000 |
| Other Financing Activities | — | — | — |
| Cash From Financing Activities | -979,118 | -2,072,891 | 147,862 |
| Change In Cash | 154,893 | -1,297,891 | -6,559,130 |
| Cash At End Of Period | 560,960 | 406,067 | 1,703,958 |
| Income Taxes Paid | 2,716,993 | 1,820,802 | 1,572,602 |
| Interest Paid | 1,976,808 | 1,808,751 | 1,259,884 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Earnings Per Share | 0.05 | -1.14 | 0.33 |
| Price To Earnings Ratio | 173.4 | -4.693 | 13.2424 |
| Earnings Growth Rate | -104.386 | -445.4545 | 26.9231 |
| Price Earnings To Growth Ratio | -1.6611 | 0.0105 | 0.4919 |
| Book Value Per Share | -1.6255 | -1.3226 | -0.1801 |
| Price To Book Ratio | -5.3339 | -4.0452 | -24.2698 |
| Ebitda | 5,467,294 | -5,339,845 | 6,985,305 |
| Enterprise Value | 81,932,533.92 | 54,035,827.65 | 46,293,704.16 |
| Dividend Yield | 0.0287 | — | 0.2074 |
| Dividend Payout Ratio | 5.025 | — | 2.7685 |
| Debt To Equity Ratio | -0.908 | -0.8901 | -7.2185 |
| Capital Expenditures | 1,380,902 | 8,517,996 | 11,492,439 |
| Free Cash Flow | 4,630,008 | 401,758 | -2,919,792 |
| Return On Equity | -0.0304 | 0.8632 | -1.8181 |
| One Year Beta | -0.0073 | 0.2545 | 0.0239 |
| Three Year Beta | 0.0907 | 0.0808 | 0.1704 |
| Five Year Beta | 0.1707 | 0.1583 | 0.1591 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| PORTNOY DAVID | Director, Chairman, Co-CEO, 10% owner | 2025-11-21 | 800 | A | 847,629 |
| PORTNOY DAVID | Director, Chairman, Co-CEO, 10% owner | 2025-11-21 | 677 | A | 12,214 |
| PORTNOY DAVID | Director, Chairman, Co-CEO, 10% owner | 2025-11-21 | 406 | A | 11,804 |
| PORTNOY DAVID | Director, Chairman, Co-CEO, 10% owner | 2025-11-21 | 273 | A | 11,212 |
| PORTNOY DAVID | Director, Chairman, Co-CEO, 10% owner | 2025-11-20 | 289 | A | 846,829 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| JPMORGAN CHASE & CO | 2025-09-30 | 51 | 11 | 4.6364 |
| CITADEL ADVISORS LLC | 2025-09-30 | 52,887 | 11,398 | 4.64 |
| NORTHERN TRUST CORP | 2025-09-30 | 133,242 | 28,716 | 4.64 |
| MORGAN STANLEY | 2025-09-30 | 2,784 | 600 | 4.64 |
| BANK OF AMERICA CORP /DE/ | 2025-09-30 | 14 | 3 | 4.6667 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| iSHARES TRUST | 2025-09-30 | iShares Micro-Cap ETF | IWC | 11,297 | 52,418.08 | 0.0053 |
| VANGUARD INDEX FUNDS | 2025-09-30 | Institutional Select Shares | VSEMX | 32,957 | 152,920.48 | 0.0002 |
| VANGUARD INDEX FUNDS | 2025-09-30 | Institutional Plus Shares | VEMPX | 32,957 | 152,920.48 | 0.0002 |
| VANGUARD INDEX FUNDS | 2025-09-30 | ETF Shares | VXF | 32,957 | 152,920.48 | 0.0002 |
| VANGUARD INDEX FUNDS | 2025-09-30 | Institutional Shares | VIEIX | 32,957 | 152,920.48 | 0.0002 |